Effects of genetic variability of CYP2D6 on neural substrates of sustained attention during on-task activity

• Published in: Translational psychiatry 2020-10, Vol.10 (1), p.338-338, Article 338
• Main Authors: Viviani, Roberto, Messina, Irene, Bosch, Julia E., Dommes, Lisa, Paul, Anna, Schneider, Katharina L., Scholl, Catharina, Stingl, Julia C.
• Format: Article
• Language: English
• Subjects: 45; 59; 59/36; 692/53/2421; 692/53/2423; Alleles; Attention; Behavioral Sciences; Biological Psychology; Cognition; Cytochrome P-450 CYP2D6 - genetics; Humans; Medicine; Medicine & Public Health; Neurosciences; Pharmacotherapy; Polymorphism, Genetic; Psychiatry
• ISSN: 2158-3188; 2158-3188
• DOI: 10.1038/s41398-020-01020-z

The polymorphic drug-metabolizing enzyme CYP2D6, which is responsible for the metabolism of most psychoactive compounds, is expressed not only in the liver, but also in the brain. The effects of its marked genetic polymorphism on the individual capacity to metabolize drugs are well known, but its role in metabolism of neural substrates affecting behavior personality or cognition, suggested by its CNS expression, is a long-standing unresolved issue. To verify earlier findings suggesting a potential effect on attentional processes, we collected functional imaging data, while N  = 415 participants performed a simple task in which the reward for correct responses varied. CYP2D6 allelic variants predicting higher levels of enzymatic activity level were positively associated with cortical activity in occipito-parietal areas as well as in a right lateralized network known to be activated by spatial attentional tasks. Reward-related modulation of activity in cortical areas was more pronounced in poor metabolizers. In conjunction with effects on reaction times, our findings provide evidence for reduced cognitive efficiency in rapid metabolizers compared to poor metabolizers in on-task attentional processes manifested through differential recruitment of a specific neural substrate.